MedTrace Logo

Making an Early Diagnosis of Talaromycosis Using a Novel Antigen Test

NCT04033120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1411

Last updated 2025-02-07

No results posted yet for this study

Summary

This is a research study to determine whether a new antigen detection test called Mp1p EIA can make an early diagnosis of talaromycosis from the blood and urine of patients. Talaromycosis is a life-threatening infection caused by a fungus endemic in Southeast Asia commonly found in patients with advanced HIV disease called Talaromyces marneffei.

Conditions

  • AIDS/HIV - RelatedDisease Associated With AIDS

Sponsors & Collaborators

  • Oxford University Clinical Research Unit, Vietnam

    collaborator OTHER

  • National Hospital for Tropical Diseases, Hanoi, Vietnam

    collaborator OTHER_GOV

  • Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

    collaborator OTHER

  • The University of Hong Kong

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Thuy Le, MD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-22
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04033120 on ClinicalTrials.gov